Platinum Industries Establishes Life Sciences Division Under Dr. Abhigyan Upadhyay's Leadership

Mumbai — Platinum Industries Ltd., an innovation-focused specialty chemicals manufacturer, has unveiled plans to diversify into life sciences, naming Dr. Abhigyan Upadhyay as the head of this newly formed business unit.

The expansion represents a strategic shift for the company, which operates across more than 30 countries and specializes in sustainable chemistry solutions for industries including plastics, paints, and coatings. The life sciences venture will operate through Rivadu Lifesciences Pvt. Ltd., a wholly owned subsidiary of Platinum Industries.

Dr. Upadhyay brings extensive credentials to the role, with over 25 years of experience in life sciences, diagnostics, regulated manufacturing, and research-intensive operations. His career includes leadership of large-scale operations, international market development, and significant involvement in clinical trial and research work during the COVID-19 pandemic.

Krishna Dushyant Rana, Chairman & Managing Director of Platinum Industries, described the move as an intentional progression of the company's commitment to responsible chemistry. "Our entry into life sciences reflects a deliberate step towards advancing our core philosophy of responsible chemistry into areas that have a direct and meaningful impact on human health. We see this as a long-term, innovation-led opportunity, and Dr. Upadhyay's experience brings the strategic depth and execution capability required to build this business in a disciplined and phased manner," Rana stated.

The company plans to begin by concentrating on research-driven segments, particularly active pharmaceutical ingredients and intermediates, while capitalizing on existing capabilities in execution and market access through strategic partnerships.

Dr. Upadhyay emphasized the importance of translating scientific knowledge into reliable, high-quality products. "The life sciences sector today is increasingly defined by the ability to translate scientific understanding into consistent, high-quality outcomes. Our focus will be on identifying the right opportunities, collaborating with partners, and bringing innovative, high-quality products to market in a phased manner," he said.

The subsidiary intends to establish a substantial international presence spanning the Middle East, United States, Europe, and Asia. This expansion aligns with growing global demand for dependable, quality-assured pharmaceutical suppliers and India's expanding role as a center for innovation-driven life sciences development.